Keyphrases
Lymphoma
100%
Non-small Cell Lung Cancer (NSCLC)
94%
JC Virus
85%
Progressive multifocal Leukoencephalopathy
84%
Diffuse Large B-cell Lymphoma (DLBCL)
82%
EGFR mutation
77%
Immunohistochemistry
72%
Alzheimer's Disease
66%
Aggressive B-cell Lymphoma
65%
Risk Factors
56%
Highly Active Antiretroviral Therapy (HAART)
48%
Proliferating Cell nuclear Antigen
46%
Cyclin D1 (CCND1)
45%
Overall Survival
43%
AIDS/HIV
42%
Virus-infected Cell
39%
MYC Translocation
39%
Lung Cancer
39%
Polymorphism
37%
Ki-67
36%
Prognostic Implications
36%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
35%
Lung Cancer Patients
35%
Desmin
34%
Epstein-Barr Virus
33%
HIV Patients
33%
MYC Protein
32%
Protein Expression
31%
Tyrosine Kinase Domain
31%
Gefitinib
31%
Prognostic Factors
31%
Cluster of Differentiation 44 (CD44)
31%
Non-Hodgkin Lymphoma
31%
Myopathy
31%
Early Protein
31%
DNA Sequencing
31%
Immunochemotherapy
31%
Immunohistochemical Expression
31%
Polymerase Chain Reaction
28%
B-cell Lymphoma 2 (Bcl-2)
28%
Non-small Cell Lung Cancer Patients
28%
Burkitt
27%
Progression-free Survival
27%
Programmed Death-ligand 1 (PD-L1)
26%
Overexpression
25%
PD-L1 Expression
25%
Epidermal Growth Factor Receptor
25%
Tumor
25%
Tumor Cells
25%
Advanced Stage
24%
Medicine and Dentistry
Diffuse Large B-Cell Lymphoma
82%
Non Small Cell Lung Cancer
77%
Human Immunodeficiency Virus
72%
B-Cell Lymphoma
70%
Lung Cancer
65%
Neoplasm
53%
Diagnosis
53%
Immunohistochemistry
48%
B Cell
40%
Protein Expression
38%
Overall Survival
36%
Epstein Barr Virus
35%
Burkitt's Lymphoma
34%
Epidermal Growth Factor Receptor
34%
Non-Hodgkin Lymphoma
32%
Prognostic Factor
32%
Programmed Death-Ligand 1
31%
Gene Amplification
31%
Highly Active Antiretroviral Therapy
31%
Cyclin D1
31%
Diseases
28%
JC Virus
23%
Retrospective Study
23%
Progressive Multifocal Leukoencephalopathy
22%
Immunophenotyping
21%
Germinal Center
21%
Fluorescence in Situ Hybridization
21%
Lung
21%
Lymphocyte
21%
Desmin
20%
Tumor Cell
20%
Myocarditis
20%
CHOP
19%
Biological Marker
19%
Acquired Immune Deficiency Syndrome
18%
Radiation Therapy
18%
Biopsy Technique
17%
B-Cell Chronic Lymphocytic Leukemia
17%
MALT Lymphoma
17%
Plasmablastic Lymphoma
16%
Hodgkin's Lymphoma
16%
Vascular Bundle
15%
Monoclonal B Cell Lymphocytosis
15%
Methylation
15%
Histiocytosis
15%
Smooth Muscle
15%
Community-Acquired Pneumonia
15%
Ulcerative Colitis
15%
X Box Binding Protein 1
15%
Blood Transfusion
15%
